Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Herbal interactions with cardiovascular drugs.

Awang DV, Fugh-Berman A.

J Cardiovasc Nurs. 2002 Jul;16(4):64-70. Review.

PMID:
12597263
2.

Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations.

Livesey J, Awang DV, Arnason JT, Letchamo W, Barrett M, Pennyroyal G.

Phytomedicine. 1999 Nov;6(5):347-9.

PMID:
11962542
3.
4.

Stimulation of interleukin-1 and -6 production in alveolar macrophages by the neotropical liana, Uncaria tomentosa (uña de gato)

Lemaire I, Assinewe V, Cano P, Awang DV, Arnason JT.

J Ethnopharmacol. 1999 Feb;64(2):109-15.

PMID:
10197746
5.

Feverfew products.

Awang DV.

CMAJ. 1997 Sep 1;157(5):510-1. No abstract available.

6.

Quality control and good manufacturing practices: safety and efficacy of commercial herbals.

Awang DV.

Food Drug Law J. 1997;52(3):341-4. No abstract available.

PMID:
10343036
7.

Siberian ginseng toxicity may be case of mistaken identity.

Awang DV.

CMAJ. 1996 Nov 1;155(9):1237. No abstract available.

8.

A bioassay for inhibition of serotonin release from bovine platelets.

Marles RJ, Kaminski J, Arnason JT, Pazos-Sanou L, Heptinstall S, Fischer NH, Crompton CW, Kindack DG, Awang DV.

J Nat Prod. 1992 Aug;55(8):1044-56.

PMID:
1431933
9.

Lack of androgenicity of Siberian ginseng.

Waller DP, Martin AM, Farnsworth NR, Awang DV.

JAMA. 1992 May 6;267(17):2329. No abstract available.

PMID:
1564770
10.

Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.

Heptinstall S, Awang DV, Dawson BA, Kindack D, Knight DW, May J.

J Pharm Pharmacol. 1992 May;44(5):391-5.

PMID:
1359053
11.

Maternal use of ginseng and neonatal androgenization.

Awang DV.

JAMA. 1991 Jul 17;266(3):363. No abstract available.

PMID:
2056644
12.

Pyrrolizidine poisoning.

Huxtable RJ, Awang DV.

Am J Med. 1990 Oct;89(4):547-8. No abstract available.

PMID:
2220897
13.

13C-NMR of Rauwolfia alkaloids.

Awang DV, Dawson BA, Neville GA, Ekiel I, Deslauriers R, Smith IC.

J Pharm Biomed Anal. 1990;8(1):91. No abstract available.

PMID:
2102269
14.

Atropine as possible contaminant of comfrey tea.

Awang DV, Kindack DG.

Lancet. 1989 Jul 1;2(8653):44. No abstract available.

PMID:
2567813
15.

Naphthoquinone Constituents of Tabebuia spp.

Girard M, Kindack D, Dawson BA, Ethier JC, Awang DV, Gentry AH.

J Nat Prod. 1988 Sep;51(5):1023-4. doi: 10.1021/np50059a044. No abstract available.

PMID:
21401189
16.

Microwave thawing of frozen drug solutions.

Awang DV, Graham KC.

Am J Hosp Pharm. 1987 Oct;44(10):2256. No abstract available.

PMID:
3687962
17.

Aggregation of commercial heparin samples in storage.

Racey TJ, Rochon P, Awang DV, Neville GA.

J Pharm Sci. 1987 Apr;76(4):314-8.

PMID:
3598891
18.

Gas chromatographic and mass spectrometric analysis of the products of methylation of sulfonylurea drugs.

Midha KK, Awang DV, McGilveray IJ.

Biomed Mass Spectrom. 1976 Jun;3(3):100-9.

PMID:
990417
20.

Pattern of phenylbutazone degradation.

Awang DV, Vincent A, Matsui F.

J Pharm Sci. 1973 Oct;62(10):1673-6. No abstract available.

PMID:
4752111

Supplemental Content

Loading ...
Support Center